Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,590.39
(
-0.52%
)
US TECH 100
23,586.40
(
-0.88%
)
Dow Jones
45,995.08
(
-0.50%
)
Brent Oil
107.54
(
0.90%
)
Bitcoin
69,891.52
(
-1.90%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122797
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: randychub post# 43071

Wednesday, 03/14/2007 8:14:39 PM

Wednesday, March 14, 2007 8:14:39 PM

Post# of 257259
>LEVP – Rodman recently set a price target of $5, surprise surprise, they also recently did a placement for Lev. Anyone here follow this stock?<

LEVP went public via a reverse merger with a popcorn company in 2004! It has only 6 employees, according to Yahoo Finance.

Perhaps more important, the competition for drugs to treat HAE is unduly intense relative to the size of the addressable market. Among the competitors are Jerini/ABT, DYAX, and Pharming.

My advice would be to pass.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now